Royce & Associates LP lowered its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 65.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,598 shares of the medical instruments supplier’s stock after selling 73,797 shares during the quarter. Royce & Associates LP owned 0.71% of Mesa Laboratories worth $5,145,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of MLAB. Ranger Investment Management L.P. acquired a new position in shares of Mesa Laboratories during the 2nd quarter valued at $17,321,000. Diamond Hill Capital Management LLC Investment Advisor bought a new position in shares of Mesa Laboratories during the 2nd quarter worth about $15,507,000. William Blair Investment Management LLC acquired a new stake in shares of Mesa Laboratories in the 3rd quarter valued at about $16,934,000. Dimensional Fund Advisors LP increased its position in Mesa Laboratories by 7.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 124,630 shares of the medical instruments supplier’s stock valued at $11,018,000 after buying an additional 8,267 shares in the last quarter. Finally, Wasatch Advisors LP increased its position in Mesa Laboratories by 125.8% in the 2nd quarter. Wasatch Advisors LP now owns 115,668 shares of the medical instruments supplier’s stock valued at $11,515,000 after buying an additional 64,435 shares in the last quarter. Institutional investors own 90.60% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have commented on MLAB shares. Wall Street Zen raised Mesa Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 3rd. Jefferies Financial Group upped their target price on Mesa Laboratories from $125.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, November 10th. Weiss Ratings upgraded Mesa Laboratories from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Finally, Wells Fargo & Company upped their price objective on shares of Mesa Laboratories from $94.00 to $110.00 and gave the stock an “equal weight” rating in a report on Friday, August 14th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Mesa Laboratories presently has an average rating of “Hold” and a consensus target price of $130.00.
Get Our Latest Research Report on Mesa Laboratories
Mesa Laboratories Stock Up 2.4%
Mesa Laboratories stock opened at $137.81 on Thursday. Mesa Laboratories, Inc. has a fifty-two week low of $69.62 and a fifty-two week high of $144.35. The stock has a market cap of $774.49 million, a PE ratio of 120.89 and a beta of 1.08. The firm’s 50-day simple moving average is $129.65 and its 200 day simple moving average is $107.10. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.39 and a current ratio of 1.90.
Mesa Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, November 30th. Mesa Laboratories’s dividend payout ratio is 56.14%.
About Mesa Laboratories
Mesa Laboratories, Inc. develops and manufactures instruments and consumable products used to monitor and control quality in life sciences and other regulated industries. Its offerings support activities such as sterilization and disinfection monitoring, laboratory testing, biopharmaceutical development, and equipment calibration. The company’s products include biological and chemical indicators, data loggers, calibration instruments, and tools used in clinical genomics and bioprocessing. Customers use these products to help verify processes, measure conditions, and meet quality requirements.
Read More
- Five stocks we like better than Mesa Laboratories
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report).
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
